Login to Your Account


VLP vaccine promising against chikungunya

By John Fox
Staff Writer

Tuesday, August 19, 2014
HONG KONG – The first human trial of a new vaccine based on virus-like particles (VLPs) suggests it is safe and effective against the rapidly emerging mosquito-borne chikungunya virus, researchers reported in the Aug. 15, 2014, early online edition of The Lancet.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription